MOTTA, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 20.194
AS - Asia 2.822
EU - Europa 2.364
SA - Sud America 351
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 4
Totale 25.792
Nazione #
US - Stati Uniti d'America 20.117
SG - Singapore 1.372
IT - Italia 549
CN - Cina 495
BR - Brasile 298
DE - Germania 273
UA - Ucraina 263
RU - Federazione Russa 256
KR - Corea 217
HK - Hong Kong 216
VN - Vietnam 202
IE - Irlanda 186
GB - Regno Unito 158
FR - Francia 154
SE - Svezia 150
PL - Polonia 104
BD - Bangladesh 93
FI - Finlandia 89
NL - Olanda 77
JP - Giappone 70
CA - Canada 55
IN - India 43
AR - Argentina 28
AT - Austria 23
ZA - Sudafrica 19
TR - Turchia 16
CZ - Repubblica Ceca 14
ES - Italia 14
UZ - Uzbekistan 14
BE - Belgio 13
EU - Europa 13
IQ - Iraq 13
ID - Indonesia 11
MX - Messico 9
EC - Ecuador 8
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
LT - Lituania 6
PK - Pakistan 6
DK - Danimarca 5
IL - Israele 5
RO - Romania 5
TN - Tunisia 5
AU - Australia 4
CR - Costa Rica 4
EG - Egitto 4
PH - Filippine 4
PY - Paraguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CL - Cile 3
IR - Iran 3
KZ - Kazakistan 3
NO - Norvegia 3
NP - Nepal 3
RS - Serbia 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
DM - Dominica 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
OM - Oman 2
TH - Thailandia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 25.791
Città #
Woodbridge 5.497
Wilmington 5.199
Houston 4.498
Fairfield 628
Singapore 607
Ann Arbor 410
Ashburn 386
Chandler 348
San Jose 307
Seattle 233
Hong Kong 212
Jacksonville 207
Beijing 204
Cambridge 187
Rome 185
Dublin 177
Council Bluffs 142
Medford 137
New York 108
Dearborn 104
Santa Clara 99
Los Angeles 81
The Dalles 81
Kraków 78
Ho Chi Minh City 65
Lawrence 65
Tokyo 57
Hanoi 51
Lauterbourg 48
Buffalo 47
San Diego 47
Munich 44
Zhengzhou 44
Dallas 42
Moscow 41
Milan 37
Manchester 32
Chicago 31
Helsinki 31
Norwalk 29
São Paulo 26
London 24
Maastricht 23
Menlo Park 19
Palo Alto 19
Warsaw 19
Mülheim 17
Orem 17
Chennai 16
Düsseldorf 16
Johannesburg 16
Hangzhou 15
Redondo Beach 15
Redwood City 15
Vienna 15
Naples 14
Brno 13
Brussels 13
Montreal 13
Amsterdam 12
Belo Horizonte 12
Boardman 12
Hefei 12
Mountain View 12
Seoul 12
Brooklyn 11
Monte Vista 11
Phoenix 11
Salt Lake City 11
Tashkent 11
University Park 11
Verona 11
Atlanta 10
Da Nang 10
Frankfurt am Main 10
Nanjing 10
Nuremberg 10
Rio de Janeiro 10
Toronto 10
Denver 9
Madrid 9
Philadelphia 9
Pieve a Nievole 9
Poplar 9
San Francisco 9
Guangzhou 8
Kunming 8
Mumbai 8
Stockholm 8
Turku 8
Eijsden 7
Haiphong 7
Ankara 6
Boston 6
Elk Grove Village 6
Ferrara 6
Hamilton 6
Mcallen 6
North Bergen 6
Ripon 6
Totale 21.526
Nome #
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 606
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 580
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 521
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 517
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 500
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 496
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 480
Subclinical central inflammation is risk for RIS and CIS conversion to MS 478
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 475
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 469
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 467
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 467
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 463
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 462
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 462
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 460
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 451
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 449
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 448
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 440
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 439
Disability and its progression can be objectively measured in multiple sclerosis 439
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 438
Inflammation inhibits GABA transmission in multiple sclerosis 438
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation 438
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 432
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 427
Endovascular Stroke Treatment of Acute Tandem Occlusion: A Single-Center Experience 426
Neural stem cell transplantation promotes post-ischemic neuronal plasticity by regulating the expression of glutamate transporters 423
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis 421
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis 420
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 418
The autonomic balance predicts cardiac responses after the first dose of fingolimod 418
CT angiography-based collateral flow and time to reperfusion are strong predictors of outcome in endovascular treatment of patients with stroke 412
Plasmacytoid dendritic cells induce an immunoregulatory T helper 9 profile in multiple sclerosis 410
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis 408
Efficacy and Safety of Mechanical Thrombectomy in Older Adults with Acute Ischemic Stoke 407
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 403
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis 399
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 398
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 394
Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum 390
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis 387
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 385
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 384
CT angiography ASPECTS predicts outcome much better than noncontrast CT in patients with stroke treated endovascularly 379
Pretreatment predictors of malignant evolution in patients with ischemic stroke undergoing mechanical thrombectomy 379
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 374
Proposed chronic cerebrospinal venous insufficienty criteria do not predict multiple sclerosis risk or severity 366
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 365
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 353
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 315
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 257
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 248
Heparin during endovascular stroke treatment seems safe 206
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 198
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 192
Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study 181
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 173
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 171
Clinical and histological study of a xenogenic bone substitute used as a filler in postextractive alveolus 153
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 146
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 122
Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation 121
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 112
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 107
Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease 103
Effects of 52 weeks of precuneus rTMS in Alzheimer's disease patients: a randomized trial 98
Decreased Frontal Gamma Activity in Alzheimer Disease Patients 95
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients 93
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study 92
Functional correlates of microglial and astrocytic activity in symptomatic sporadic Alzheimer's disease: a CSF/18F-FDG-PET study 83
Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients 67
Improving visuo-motor learning with cerebellar theta burst stimulation: behavioral and neurophysiological evidence 65
Biobanking for Neurodegenerative Diseases: Challenge for Translational Research and Data Privacy 59
Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer's Disease 58
Intermittent cerebellar theta burst stimulation improves visuo-motor learning in stroke patients: a pilot study 55
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum 46
Rethinking dementia in the oldest old: Lessons to learn for the diagnosis and treatment of Alzheimer’s disease 38
Beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies 33
Reply to: letter to the editor regarding “beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies” 29
Reframing TDP‐43 in Alzheimer's disease: From co‐pathology to neurovascular culprit 29
Elevated plasma p-tau217 in newborns: developmental signal or synaptic stress marker? 27
Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum. 26
Opposing patterns of blood-brain barrier permeability and Alzheimer’s disease biomarkers across APOE genotype 23
Chronic fasudil treatment induces benzodiazepine-like tolerance via modulation of GABA-A receptor γ2 subunit expression and impairs contextual fear memory in mice 19
Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial 19
Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection 18
NOTCH3 variants of unknown significance underpin vascular dysfunction in neurodegenerative disease: a case series of three nfvPPA-FTD patients 15
An Out-of-Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic 12
Streamlining Alzheimer's disease diagnosis: real-world validation of two-cut-off diagnostic models based on plasma p-tau/Aβ42 ratios 11
Totale 26.176
Categoria #
all - tutte 60.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022772 40 98 75 37 26 84 36 28 54 55 50 189
2022/2023850 119 90 20 103 73 187 62 49 63 12 53 19
2023/2024254 37 7 22 12 22 70 12 4 3 5 8 52
2024/20252.154 66 374 179 113 74 256 112 89 149 176 321 245
2025/20263.511 249 161 373 262 312 124 460 357 457 281 275 200
Totale 26.176